Details

Autor(en) / Beteiligte

• Mungo, Benedetto
• Hammad, Abdulrahman
• AlMasri, Samer
• Dogeas, Epameinondas
• Nassour, Ibrahim
• Singhi, Aatur D.
• Zeh, Herbert J.
• Hogg, Melissa E.
• Lee, Kenneth K. W.
• Zureikat, Amer H.
• Paniccia, Alessandro

Titel

Pancreaticoduodenectomy for benign and premalignant pancreatic and ampullary disease: is robotic surgery the better approach?

Ist Teil von

• Surgical endoscopy, 2023-02, Vol.37 (2), p.1157-1165

Ort / Verlag

New York: Springer US

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Background The robotic platform is increasingly being utilized in pancreatic surgery, yet its overall merits and putative advantages remain to be adjudicated. We hypothesize that the benefits of minimally invasive pancreatic surgery are maximized in pancreatic benign and premalignant disease, in the setting of friable pancreatic tissue and small pancreatic duct. Methods Retrospective analysis of our prospectively maintained pancreatic database of all consecutive patients who underwent pancreaticoduodenectomy (PD) for benign or premalignant conditions between 2010 and 2020. Peri-operative outcomes and long-term complications were compared between robotic pancreaticoduodenectomy (RPD) and open pancreaticoduodenectomy (OPD). Results One hundred and eighty eight ( n  = 188) patients met our inclusion criteria, of which 68 were OPD and 120 RPD. Malignant histologies were excluded. There were only minor differences in baseline characteristics between the two groups. Post-operative merits of the RPD included lower clinically relevant post-operative pancreatic fistula 10 (8.3%) vs 24 (35.3%), p  < 0.001, fewer surgical site infections; 9 (7.5%) vs 11 (16.2%), p  = 0.024, shorter operative time, greater lymph node yield; 29 (IQR 21, 38) vs 21 (IQR 13, 34), p  = 0.001, and lower 90 days mortality; 1 (0.8%) vs 4 (5.9%), p  = 0.039. Rates of long-term complications were similar, exception made for a higher occurrence of small bowel obstruction (SBO) 2 (1.7%) vs 4 (5.9%), p  = 0.031 and need for surgical intervention for SBO 0 (0.0%) vs 2 (2.9%), p  = 0.019 in the OPD group. Conclusion Our study suggests that RPD benefits include lower 90-day mortality, shorter LOS, and lower rates of selected complications compared to open pancreaticoduodenectomy.